Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Canada OKs Restore Medical's OSA (obstructive sleep apnoea) technology:

This article was originally published in Clinica

Executive Summary

Restore Medical has received market approval from Health Canada for its Pillar palatable implant system for treating snoring and mild-to-moderate obstructive sleep apnoea (OSA). The device - already available in 24 countries including the US - will be distributed throughout Canada by Ontario-based Southmedic. The Pillar system is implanted during a single office visit using local anaesthetic. During the procedure, three small polyester implants are placed at the back of the roof of the mouth in order to support and stiffen the tissue, eliminating tissue flutter in snoring or collapse of the soft palate, as in OSA.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052904

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel